Evidence map›Paper›PMID 40673158›Full record

ArticleFrontiers in microbiology2025

Molecular epidemiology of a carbapenem-resistant

Letícia Fernandes da Rocha, Grazielle Motta Rodrigues, Gabriela Simões de Oliveira, Aymê Duarte Echevarria, Priscila Wink, Fabiana Volpato, Mayana Berdichevski, Larissa Lutz, Dariane Castro Pereira, Afonso Luís Barth and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. International journal of molecular sciences · 2026
    Review
  2. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Letícia Fernandes da Rocha *Unidade de Microbiologia e Biologia Molecular, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Grazielle Motta Rodrigues *PPGCM - Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Gabriela Simões de OliveiraPPGCF - Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Aymê Duarte EchevarriaLABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Priscila WinkLABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Fabiana VolpatoLABRESIS - Laboratório de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Mayana BerdichevskiPPGCF - Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Larissa LutzUnidade de Microbiologia e Biologia Molecular, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Dariane Castro PereiraUnidade de Microbiologia e Biologia Molecular, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Afonso Luís BarthPPGCM - Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Andreza Francisco MartinsPPGCM - Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: This study aimed to characterize a carbapenem-resistant Results: Among the 170 carbapenem-resistant Discussion: Our findings indicate that the flagellin gene serves as an effective marker for characterizing carbapenem-resistant

Indexed as

blaKPCfliCIncP6 plasmidSerratia marcescenssingle-locus sequence typing

Identifiers

PMID40673158
PMCPMC12263918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.